MJardin Group, Inc. (MJARF) Financials
MJARF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2021 | 67.8 million | 164.2 million |
| June 30, 2021 | 81.6 million | 162.1 million |
| March 31, 2021 | 83.1 million | 156.4 million |
| Dec. 31, 2020 | 79.2 million | 149.7 million |
MJARF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2021 | -1.7 million | 40745 |
| June 30, 2021 | 2.5 million | 599815 |
| March 31, 2021 | -998343 | 395949 |
| Dec. 31, 2020 | -8.4 million | 373362 |
MJARF Net Income
No data available :(
MJARF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2021 | 494065 | 134.7 million | 2.5 million |
| June 30, 2021 | 781407 | 132.4 million | 2.6 million |
| March 31, 2021 | 444607 | 2.2 million | 2.6 million |
| Dec. 31, 2020 | 1.2 million | 1.9 million | 2.6 million |
MJARF Shares Outstanding
MJARF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2021 | 14189 | - | 1.5 million | - |
| June 30, 2021 | 877163 | - | 2.1 million | - |
| March 31, 2021 | 517395 | - | 1.2 million | - |
| Dec. 31, 2020 | 507302 | - | 2.9 million | - |
MJARF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2021 | 1.0 million | 2.8 million |
| June 30, 2021 | 884689 | 2.0 million |
| March 31, 2021 | 1.0 million | 401194 |
| Dec. 31, 2020 | 1.9 million | 296046 |
MJARF
Price: $0
52 week price:
Earnings Per Share: -0.45 USD
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 90140